Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4028810 | Ophthalmology | 2009 | 7 Pages |
ObjectiveTo evaluate the incidence, effect on visual recovery, and predisposing risk factors of postvitrectomy macular edema (ME).DesignProspective cohort study.ParticipantsOne-hundred nine eyes undergoing nonemergent vitrectomy surgery.MethodsEyes were evaluated for postoperative day 1 inflammation, 1-month retinal thickness using optical coherence tomography, and preoperative and 1-month postoperative best-corrected visual acuity (BCVA). Macular edema was defined as central subfield thickness ≥272 μm.Main Outcome MeasuresRetinal thickness, inflammation, and BCVA.ResultsIncidence of ME on optical coherence tomography was 47% (95% confidence interval [CI], 37%–56%). Mean 1-month visual acuity improved 3.3 lines (0.33 logarithm of minimum angle of resolution [logMAR] units) to 20/80+1 (0.58±0.46 logMAR units) from 20/150–2 (0.91±0.63 logMAR units) before surgery (P<0.001). Mean 1-month center point thickness (CPT), central subfield (CSF), and total macular volume were 265±107 μm, 288±94 μm, and 7.8±1.2 mm3, respectively. Severity of postoperative inflammation predicted retinal thickness at 1 month (P<0.05). Intraoperative epinephrine use was associated with increased postoperative inflammation (P = 0.02). Eyes with greater reduction in CSF (or CPT) from baseline experienced more rapid visual recovery (r = –0.36; 95% CI, –0.61 to –0.06; P = 0.02).ConclusionsPostvitrectomy ME is common and delays visual recovery. Degree of postoperative inflammation is an important risk factor for ME and, in this series, was increased in the setting of intraocular epinephrine. Efforts to reduce or prevent inflammation after vitrectomy should be beneficial and therefore are encouraged.Financial Disclosure(s)The author(s) have no proprietary or commercial interest in any materials discussed in this article.